Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 753-759

  Nakahashi, Takuya ^a   Arita, Takeshi ^a   Yamaji, Kyohei ^a   Inoue, Katsumi ^a   Yokota, Tadaaki ^a   Hoshii, Yoshinobu ^b   Fukunaga, Masato ^a   Nomura, Akihiro ^a   Watanabe, Hirotoshi ^a   Miura, Shirou ^a   Isotani, Akihiro ^a   Soga, Yoshimitsu ^a   Ando, Kenji ^a   Iwabuchi, Masashi ^a   Yokoi, Hiroyoshi ^a   Nosaka, Hideyuki ^a   Yamagishi, Masakazu ^c   Nobuyoshi, Masakiyo ^a  

^a KOKURA MEMORIAL HOSPITAL   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Cardiac amyloidosis; Endomyocardial biopsy; Left ventricular function; Prognosis

Indexed keywords

AGED; AMYLOIDOSIS; BIOPSY; CARDIOMYOPATHY; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART MUSCLE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; SURVIVAL RATE; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMYLOIDOSIS; BIOPSY; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; SURVIVAL RATE;

EID: 84908231988     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.100     Document Type: Article

References (31)

1. R.H. Falk Diagnosis and management of the cardiac amyloidoses Circulation 112 2005 2047 2060
2. S.W. Dubrey, K. Cha, and J. Anderson The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement QJM 91 1998 141 157
3. M. Skinner, V. Sanchorawala, and D.C. Seldin High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study Ann Intern Med 140 2004 85 93
4. R.A. Kyle, P.C. Spittell, and M.A. Gertz The premortem recognition of systemic senile amyloidosis with cardiac involvement Am J Med 101 1996 395 400
5. J.H. Pinney, C.J. Whelan, and A. Petrie Senile systemic amyloidosis: clinical features at presentation and outcome J Am Heart Assoc 2 2013 e000098
6. H.J. Lachmann, D.R. Booth, and S.E. Booth Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis N Engl J Med 346 2002 1786 1791
7. M.M. Picken, G. Gallo, and J. Buxbaum Characterizaton of renal amyloid derived from the variable region of the lambda light chain subgroup II Am J Pathol 124 1986 82 87
8. Y. Hoshii, M. Setoguchi, and T. Iwata Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis Pathol Int 51 2001 264 270
9. P.A. McKee, W.P. Castelli, and P.M. McNamara The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1971 1441 1446
10. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
11. A. Hansen, M. Haass, and C. Zugck Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure J Am Coll Cardiol 37 2001 1049 1055
12. M. Quintana, M. Edner, and T. Kahan Is left ventricular diastolic function an independent maker of prognosis after acute myocardial infarction? Int J Cardiol 96 2004 183 189
13. C.M. O'Connor, A.B. Miller, and J.E. Blair Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program Am Heart J 159 2010 841 849
14. J.P. Hamer, S. Janssen, and M.H. van Rijswijk Amyloid cardiomyopathy in systemic non-hereditary amyloidosis: clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis Eur Heart J 13 1992 623 627
15. B. Ng, L.H. Connors, and R. Davidoff Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis Arch Intern Med 165 2005 1425 1429
16. B.A. Austin, B. Duffy, and C. Tan Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis Am J Cardiol 103 2009 1429 1433
17. A. Biolo, S. Ramamurthy, and L.H. Connors Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition Circ Heart Fail 1 2008 249 257
18. R.J. Strege, W. Saeger, and R.P. Linke Diagnosis and immunohistochemical classification of systemic amyloidoses: report of 43 cases in an unselected autopsy series Virchows Arch 433 1998 19 27
19. R.R. Smith, and G.M. Hutchins Ischemic heart disease secondary to amyloidosis of intramyocardial arteries Am J Cardiol 44 1979 413 417
20. P.S. Muller, W.D. Edwards, and M.A. Gertz Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis Am J Med 109 2000 181 188
21. T.B. Crotty, C.Y. Li, and W.D. Edwards Amyloidosis and endomyocardial biopsy: correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases Cardiovasc Pathol 4 1995 39 42
22. M.A. Gertz, M. Grogan, and R.A. Kyle Endomyocardial biopsy-proven light chain amyloidosis (AL) without echocardiographic features of infiltrative cardiomyopathy Am J Cardiol 80 1997 93 95
23. C. Rapezzi, G. Merlini, and C.C. Quarta Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types Circulation 120 2009 1203 1212
24. F.L. Ruberg, M.S. Maurer, and D.P. Judge Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS) Am Heart J 164 2012 222 228
25. T. Bhuiyan, S. Helmke, and A.R. Patel Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS) Circ Heart Fail 4 2011 121 128
26. P.L. Temporelli, P. Giannuzzi, and G.L. Nicolosi Doppler-derived mitral deceleration time as a strong prognostic marker of left ventricular remodeling and survival after acute myocardial infarction: results of the GISSI-3 echo substudy J Am Coll Cardiol 43 2004 1646 1653
27. A.L. Klein, L.K. Hatle, and C.P. Taliercio Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis: a Doppler echocardiography study Circulation 83 1991 808 816
28. R.H. Falk Cardiac amyloidosis: a treatable disease, often overlooked Circulation 124 2011 1079 1085
29. J. Koyama, P.A. Ray-Sequin, and R.H. Falk Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis Circulation 107 2003 2446 2452
30. J. Koyama, and R.H. Falk Prognostic significance of strain Doppler imaging in light-chain amyloidosis JACC Cardiovasc Imaging 3 2010 333 342
31. F. Ogiwara, J. Koyama, and S. Ikeda Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis Am J Cardiol 95 2005 538 540